INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 192 filers reported holding INSMED INC in Q3 2021. The put-call ratio across all filers is 1.27 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,085,550 | -13.4% | 122,200 | -27.6% | 0.00% | 0.0% |
| Q2 2023 | $3,562,588 | +21.0% | 168,843 | -2.2% | 0.00% | 0.0% |
| Q1 2023 | $2,944,621 | -52.0% | 172,705 | -43.7% | 0.00% | -50.0% |
| Q4 2022 | $6,131,822 | +540.7% | 306,898 | +590.4% | 0.00% | – |
| Q3 2022 | $957,000 | -36.9% | 44,455 | -42.2% | 0.00% | -100.0% |
| Q2 2022 | $1,516,000 | -70.5% | 76,852 | -64.8% | 0.00% | -50.0% |
| Q1 2022 | $5,131,000 | +0.1% | 218,342 | +16.0% | 0.00% | +100.0% |
| Q4 2021 | $5,128,000 | +104.4% | 188,267 | +106.6% | 0.00% | 0.0% |
| Q3 2021 | $2,509,000 | +533.6% | 91,110 | +554.2% | 0.00% | – |
| Q2 2021 | $396,000 | -77.2% | 13,927 | -72.7% | 0.00% | -100.0% |
| Q1 2021 | $1,734,000 | +219.9% | 50,925 | +212.6% | 0.00% | – |
| Q4 2020 | $542,000 | -0.4% | 16,292 | -3.6% | 0.00% | – |
| Q3 2020 | $544,000 | +26.2% | 16,909 | +7.9% | 0.00% | – |
| Q2 2020 | $431,000 | -23.0% | 15,666 | -55.2% | 0.00% | – |
| Q1 2020 | $560,000 | -11.5% | 34,945 | +31.8% | 0.00% | – |
| Q4 2019 | $633,000 | -83.4% | 26,515 | -87.7% | 0.00% | -100.0% |
| Q3 2019 | $3,804,000 | +137.2% | 215,655 | +244.0% | 0.00% | 0.0% |
| Q2 2019 | $1,604,000 | +269.6% | 62,682 | +320.1% | 0.00% | – |
| Q1 2019 | $434,000 | -82.6% | 14,921 | -92.1% | 0.00% | -100.0% |
| Q4 2018 | $2,489,000 | +269.3% | 189,698 | +469.7% | 0.00% | – |
| Q3 2018 | $674,000 | +57.8% | 33,299 | +84.5% | 0.00% | – |
| Q2 2018 | $427,000 | -83.9% | 18,052 | -84.6% | 0.00% | -100.0% |
| Q1 2018 | $2,647,000 | +310.4% | 117,567 | +468.8% | 0.00% | – |
| Q4 2017 | $645,000 | -9.8% | 20,670 | -9.8% | 0.00% | – |
| Q3 2017 | $715,000 | +65.9% | 22,921 | -8.7% | 0.00% | – |
| Q2 2017 | $431,000 | -28.9% | 25,114 | -27.4% | 0.00% | – |
| Q1 2017 | $606,000 | -51.2% | 34,614 | -63.2% | 0.00% | -100.0% |
| Q4 2016 | $1,243,000 | -62.2% | 93,953 | -58.5% | 0.00% | -50.0% |
| Q3 2016 | $3,289,000 | +40.3% | 226,513 | -4.7% | 0.00% | +100.0% |
| Q2 2016 | $2,344,000 | -51.7% | 237,759 | -37.9% | 0.00% | -66.7% |
| Q1 2016 | $4,851,000 | -65.0% | 382,810 | -49.9% | 0.00% | -66.7% |
| Q4 2015 | $13,869,000 | -13.7% | 764,149 | -11.7% | 0.01% | -18.2% |
| Q3 2015 | $16,076,000 | -32.2% | 865,680 | -10.9% | 0.01% | -31.2% |
| Q2 2015 | $23,713,000 | +1.0% | 971,053 | -14.0% | 0.02% | 0.0% |
| Q1 2015 | $23,483,000 | +36.3% | 1,128,978 | +1.4% | 0.02% | +33.3% |
| Q4 2014 | $17,223,000 | – | 1,113,337 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |